Quality of life in patients with advanced gastroesophageal (GE) adenocarcinoma treated with modified docetaxel, cisplatin, and fluorouracil (mDCF)

被引：0
|
作者：
Smyth, E. C.
Janjigian, Y. Y.
Robinson, E.
Sheehy, E. C.
Karpenko, I.
Capanu, M.
Kelsen, D. P.
Shah, M. A.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med Oncol, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.92
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
92
引用
收藏
页数：1
相关论文
共 50 条
  • [21] BIMONTHLY REGIMEN OF HIGH DOSE LEUCOVORIN, INFUSIONAL 5-FLUOROURACIL, DOCETAXEL AND CISPLATIN (MODIFIED DCF) IN ADVANCED GASTRIC ADENOCARCINOMA
    Unek, I. T.
    Akman, T.
    Oztop, I.
    Unal, O. U.
    Salman, T.
    Yilmaz, A. U.
    ANNALS OF ONCOLOGY, 2012, 23 : 234 - 234
  • [22] The efficacy of modified docetaxel, cisplatin and 5-fluorouracil in advanced stage gastric carcinoma
    Yildirim, N. Ozdemir
    Abali, H.
    Oksuzoglu, B.
    Budakoglu, B.
    Uncu, D.
    Guler, T.
    Odabasi, H.
    Cihan, S.
    Zengin, N.
    EJC SUPPLEMENTS, 2009, 7 (02): : 370 - 370
  • [23] Efficacy of the Combination of Modified Docetaxel, Cisplatin and Fluorouracil in Locally Advanced Gastric Cancer: Evaluation of Real-Life Outcomes
    Eren, Tulay
    Karacin, Cengiz
    Ucar, Gokhan
    Ergun, Yakup
    Yazici, Ozan
    Imamoglu, Goksen Inanc
    Bostanci, Birol
    Ozdemir, Nuriye
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2020, 30 (01): : 23 - 31
  • [24] Quality of life in patients with advanced gastric cancer sequentially treated with docetaxel and irinotecan with 5-fluorouracil and folinic acid (leucovin)
    Gubanski, M.
    Glimelius, B.
    Lind, P. A.
    MEDICAL ONCOLOGY, 2014, 31 (04)
  • [25] Quality of life in patients with advanced gastric cancer sequentially treated with docetaxel and irinotecan with 5-fluorouracil and folinic acid (leucovin)
    M. Gubanski
    B. Glimelius
    P. A. Lind
    Medical Oncology, 2014, 31
  • [26] A phase III study of S-1 plus cisplatin versus fluorouracil plus cisplatin in patients with advanced gastric or gastroesophageal junction adenocarcinoma
    Xu, Rui-hua
    Sun, Guo-ping
    Lu, Hui-shan
    Peng, Liu Yun
    Xu, Jian-ming
    Zhong, Mei-zuo
    Zhang, He-long
    Yu, Shi-ying
    Li, Wei
    Hu, Xiao-hua
    Wang, Jie Jun
    Cheng, Ying
    Zhou, Jun-tian
    Guo, Zeng-qing
    Guan, Zhongzhen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial
    Kim, Stefano
    Buecher, Bruno
    Andre, Thierry
    Jary, Marine
    Bidard, Francois-Clement
    Ghiringhelli, Francois
    Francois, Eric
    Taieb, Julien
    Smith, Denis
    de la Fouchardiere, Christelle
    Desrame, Jerome
    Samalin, Emmanuelle
    Parzy, Aurelie
    Baba-Hamed, Nabil
    Bouche, Olivier
    Tougeron, David
    Dahan, Laetitia
    El Hajbi, Farid
    Jacquin, Marion
    Rebucci-Peixoto, Magali
    Spehner, Laurie
    Vendrely, Veronique
    Vernerey, Dewi
    Borg, Christophe
    BMC CANCER, 2020, 20 (01)
  • [28] Optimizing docetaxel chemotherapy in patients with cancer of the gastric and Gastroesophageal junction - Evolution of the Docetaxel, Cisplatin, and 5-fluorouracil regimen
    Ajani, Jaffer A.
    CANCER, 2008, 113 (05) : 945 - 955
  • [29] Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial
    Stefano Kim
    Bruno Buecher
    Thierry André
    Marine Jary
    François-Clément Bidard
    François Ghiringhelli
    Éric François
    Julien Taieb
    Denis Smith
    Christelle de la Fouchardière
    Jérôme Desramé
    Emmanuelle Samalin
    Aurélie Parzy
    Nabil Baba-Hamed
    Olivier Bouché
    David Tougeron
    Laëtitia Dahan
    Farid El Hajbi
    Marion Jacquin
    Magali Rebucci-Peixoto
    Laurie Spehner
    Véronique Vendrely
    Dewi Vernerey
    Christophe Borg
    BMC Cancer, 20
  • [30] Bimonthly regimen of high-dose leucovorin, infusional 5-fluorouracil, docetaxel, and cisplatin (modified DCF) in advanced gastric adenocarcinoma
    Unek, Ilkay Tugba
    Akman, Tulay
    Oztop, Ilhan
    Unal, Olcun Umit
    Salman, Tarik
    Yilmaz, Ugur
    GASTRIC CANCER, 2013, 16 (03) : 428 - 434
12345